Results 221 to 230 of about 103,495 (263)
Some of the next articles are maybe not open access.

Autoantibodies against Cardiac Troponins

New England Journal of Medicine, 2005
To the Editor: Cardiac troponins are preferred markers of tissue injury in acute coronary syndromes.
Susann, Eriksson   +2 more
openaire   +2 more sources

Characteristics of cardiac troponin measurements

Coronary Artery Disease, 2013
Cardiac troponin I (cTnI) and T (cTnT) have displaced myoglobin and creatine kinase-MB as the preferred markers of myocardial injury and have become the cornerstones for diagnosis of myocardial infarction (MI). Current guidelines for MI diagnosis give specific recommendations for cTnI and cTnT assays including instructions to reliably measure values in
Eric, Christenson, Robert H, Christenson
openaire   +2 more sources

[Cardiac troponin].

Nederlands tijdschrift voor geneeskunde, 2012
Measurement of cardiac troponins (cTnT and cTnI), the only cardiac specific biomarkers available, is the gold standard in diagnosing acute coronary syndrome. Due to the recent introduction of more sensitive methods i.e. the high-sensitivity troponin assays, the diagnostic cut-off concentrations have very recently been established.
Alma M A, Mingels   +2 more
openaire   +1 more source

Cardiac troponin testing in cardiac surgery

Expert Review of Cardiovascular Therapy, 2023
Peter A, Kavsak   +3 more
openaire   +2 more sources

Cardiac Troponin*

The Journal of Biochemistry, 1973
R, Tsukui, S, Ebashi
openaire   +2 more sources

Cardiac Troponins in Pediatrics

Pediatric Emergency Care, 2004
Usama B, Kanaan, Vincent W, Chiang
openaire   +2 more sources

Cardiac troponins

The Lancet, 1998
PO Collinson, R Canepa-Anson, S Joseph
openaire   +2 more sources

Assays for Cardiac Troponins

JAMA, 2013
Jacobus P J, Ungerer   +2 more
openaire   +2 more sources

Cardiac Troponin

Hospital Medicine Clinics, 2016
David M. Nemer, Hicham Skali
openaire   +1 more source

Cardiac Troponin

Chest, 1997
Chris S. Brown, Barry D. Bertolet
openaire   +2 more sources

Home - About - Disclaimer - Privacy